Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R. 1959, Preserving Patient Access to Compounded Medications Act of 2019.
Patient access to compound medicines. Medicare patient access to compounded medications.
Monitor FY20 Appropriations bills as they relate to compounded medications.
Duration: March 24, 2015
to
March 31, 2020
General Issues: Pharmacy , Medicare/Medicaid , Budget/Appropriations , Defense , Veterans
Spending: about $1,010,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Bud Cramer Former Member of Congress, U.S. House of Representatives
Jefferies Murray Chief of Staff to Congressman Bud Cramer
Legislative Director to Congressman Bill Brewster
Chief of Staff to Congressman Bud Cramer, Legislative Director to Congressman Bill Brewster
Nelson Litterst Special Assistant to the President for Legislative Affairs
Scott Styles Chief of Staff, Congressman Pete Sessions
Leg. Aide, State Department
Chief of Staff to Congressman Pete Sessions, Legislative Aide, State Department
Chief of Staff, Congressman Pete Sessions, Leg. Aide, State Department
D. Patrick Robertson n/a
Patrick Robertson n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2020
FTI Government Affairs terminated an engagement in which they represented Professional Compounding Centers of America on Aug. 10, 2020.
Original Filing: 301205045.xml
1st Quarter, 2020
In Q1, FTI Government Affairs did no lobbying for Professional Compounding Centers of America . The report was filed on April 17, 2020.
Original Filing: 301170963.xml
4th Quarter, 2019
In Q4, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on Jan. 17, 2020.
Original Filing: 301109988.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R. 1959, Preserving Patient Access to Compounded Medications Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY20 Appropriations bills as they relate to compounded medications.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069957.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R. 1959, Preserving Patient Access to Compounded Medications Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY20 Appropriations bills as they relate to compounded medications.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on July 22, 2019.
Original Filing: 301055768.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R. 1959, Preserving Patient Access to Compounded Medications Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY20 Appropriations bills as they relate to compounded medications.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on April 22, 2019.
Original Filing: 301034210.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R. 1959, Preserving Patient Access to Compounded Medications Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY20 Appropriations bills as they relate to compounded medications.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006919.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 "Preserving Patient Access to Compounded Medication Act of 2017. "
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY19 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on Oct. 17, 2018.
Original Filing: 300987371.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 "Preserving Patient Access to Compounded Medication Act of 2017. "
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY19 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on July 19, 2018.
Original Filing: 300969582.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 "Preserving Patient Access to Compounded Medication Act of 2017. "
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY19 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on April 18, 2018.
Original Filing: 300948247.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 "Preserving Patient Access to Compounded Medication Act of 2017. "
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY18 & FY19 Appropriations as it relates to Agriculture. "Consolidated Appropriations Act, 2018", H.R. 1625.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on Jan. 19, 2018.
Original Filing: 300928222.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 "Preserving Patient Access to Compounded Medication Act of 2017. "
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY18 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on Oct. 19, 2017.
Original Filing: 300910115.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 "Preserving Patient Access to Compounded Medication Act of 2017. "
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY18 Appropriations as it relates to Agriculture. Monitor, "Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018" H.R. 3354
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on July 19, 2017.
Original Filing: 300888838.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). Monitor H.R.2871 "Preserving Patient Access to Compounded Medication Act of 2017. "
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY18 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on April 18, 2017.
Original Filing: 300868086.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines. Medicare patient access to compounded medications.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2017. Department of Defense Appropriations Act, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY17 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on Jan. 17, 2017.
Original Filing: 300847885.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2017. Department of Defense Appropriations Act, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY17 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on Oct. 20, 2016.
Original Filing: 300837184.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2017. Department of Defense Appropriations Act, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY17 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on July 20, 2016.
Original Filing: 300817884.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2017. Department of Defense Appropriations Act, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY17 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on April 20, 2016.
Original Filing: 300798973.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2017. Department of Defense Appropriations Act, 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY17 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $60,000. The report was filed on Jan. 20, 2016.
Original Filing: 300781556.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
"National Defense Authorization Act for Fiscal Year 2016," H.R.1735. "National Defense Authorization Act for Fiscal Year 2016," S.1376. "Department of Defense Appropriations Act", 2016, H.R.2685. "Department of Defense Appropriations Act, 2016," S.1558.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY16 Appropriations as it relates to Agriculture. The Consolidated Appropriations Act, 2016, House Amendment #1 to the Senate Amendment to H.R. 2029, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2016.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $50,000. The report was filed on Oct. 20, 2015.
Original Filing: 300762667.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
"National Defense Authorization Act for Fiscal Year 2016," H.R.1735. "National Defense Authorization Act for Fiscal Year 2016," S.1376. "Department of Defense Appropriations Act", 2016, H.R.2685. "Department of Defense Appropriations Act, 2016," S.1558.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY16 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, FTI Government Affairs lobbied for Professional Compounding Centers of America , earning $30,000. The report was filed on July 16, 2015.
Original Filing: 300737334.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
"National Defense Authorization Act for Fiscal Year 2016," H.R.1735. "National Defense Authorization Act for Fiscal Year 2016," S.1376
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor FY16 Appropriations as it relates to Agriculture.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, FTI Government Affairs lobbied for Professional Compounding Centers of America . The report was filed on April 17, 2015.
Original Filing: 300719183.xml
Lobbying Issues
Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Patient access to compound medicines
Agencies Lobbied
U.S. Senate
Lobbying Issues
Military patient access, Tricare.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
FTI Government Affairs filed a lobbying registration on April 2, 2015 to represent Professional Compounding Centers of America, effective March 24, 2015.
Original Filing: 300712323.xml
Issue(s) they said they’d lobby about: Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law); Patient access to compound medicines; Military patient access, Tricare. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...